Prudential Financial
GBIO

Prudential Financial’s Generation Bio GBIO Stock Holding History

Prudential Financial’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,210
Closed -$7.07K – 2468
2025
Q2 		$7.07K Sell
2,210
-1,348
-38% -$5.19K ﹤0.01% 2422
2025
Q1 		$14.4K Sell
3,558
-1,540
-30% -$10.8K ﹤0.01% 2275
2024
Q4 		$54K Hold
5,098
– – ﹤0.01% 2203
2024
Q3 		$126K Hold
5,098
– – ﹤0.01% 2561
2024
Q2 		$144K Buy
5,098
+980
+24% +$31.8K ﹤0.01% 2521
2024
Q1 		$168K Buy
4,118
+1,280
+45% +$30.1K ﹤0.01% 2486
2023
Q4 		$46.8K Buy
+2,838
New +$49.5K ﹤0.01% 2562

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prudential Financial's GBIO Position: Q3 2025 in Review

Prudential Financial sold out of Generation Bio (GBIO) in Q3 2025, closing a stake of 2,210 shares — an estimated $7.07K sold.

Prudential Financial first reported a position in GBIO in Q4 2023 and held it in 7 quarters. The position peaked at $168K in Q1 2024. 41 funds tracked by Wall St. Rank hold GBIO as of Q3 2025.

  • Prudential Financial reported no remaining Generation Bio position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 2,210 Generation Bio shares in Q3 2025, an estimated $7.07K.
  • Prudential Financial first reported a position in Generation Bio in Q4 2023 and held it in 7 quarters.
  • Prudential Financial's Generation Bio position peaked at $168K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Generation Bio as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.